Bill Information > SB 6234
Search for another bill or initiative:
Search
SB 6234 - 2023-24
Screening newborn infants for branched-chain ketoacid dehydrogenase kinase deficiency.
Bill History
2024 REGULAR SESSION
IN THE SENATE
Jan 15
First reading, referred to Health & Long Term Care.
(View Original Bill)
Jan 25
Public hearing in the Senate Committee on Health & Long Term Care at 10:30 AM.
(Committee Materials)
Jan 30
Executive action taken in the Senate Committee on Health & Long Term Care at 8:00 AM.
(Committee Materials)
HLTC - Majority; do pass.
(Majority Report)
Minority; without recommendation.
(Minority Report)
Jan 31
Passed to Rules Committee for second reading.
Feb 6
Placed on second reading by Rules Committee.
Feb 7
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1.
(View Roll Calls)
IN THE HOUSE
Feb 9
First reading, referred to Health Care & Wellness.
Feb 21
Public hearing and executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee Materials)
HCW - Majority; do pass.
(Majority Report)
Referred to Rules 2 Review.
Feb 24
Rules Committee relieved of further consideration. Placed on second reading.
Feb 27
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 96; nays, 0; absent, 0; excused, 2.
(View Roll Calls)
IN THE SENATE
Feb 28
President signed.
IN THE HOUSE
Feb 29
Speaker signed.
OTHER THAN LEGISLATIVE ACTION
Mar 7
Delivered to Governor.
(View Bill as Passed Legislature)
Mar 14
Governor signed.
Chapter 105, 2024 Laws.
(View Session Law)
Effective date 6/6/2024.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
(No Amendments)
Available Videos
(Video links take you to the TVW website)
Live video is available at the stated time. Archived video becomes available approximately two hours after the close of the hearing or floor session.
Live video is available at the stated time. Archived video becomes available approximately two hours after the close of the hearing or floor session.